-- 週三,受全球原油價格下跌以及媒體報道川普政府與伊朗進行和平談判的消息提振,亞洲股市普遍走高。隔夜華爾街股市再創新高,也為市場定調了。 香港和上海股市收漲,東京股市因假期休市。 首爾綜合指數(KOSPI)上漲6.5%,突破7000點大關,科技和半導體板塊表現強勁,其中三星電子股價上漲14.4%。 香港恆生指數開盤走低,最終收漲1.2%,交易員關注波斯灣局勢,注意到布蘭特原油價格在交易時段下跌7%。房地產板塊的上漲也提振了其他股指。 恆生指數上漲315.17點,收在26,213.78點,上漲個股數量超過下跌個股,比例為67比22。恆生科技指數當日上漲0.8%,中國內地產指數上漲4.6%。 信義玻璃領漲,漲幅達9.8%,理想汽車下跌2.6%。 中國內地方面,上證綜指上漲1.2%,收在4,160.17點。 其他地區交易所方面,台灣加權指數上漲0.9%;澳洲ASX 200指數上漲1.3%;新加坡海峽時報指數上漲0.1%;泰國S10指數上漲1.8%。孟買Sensex指數尾盤上漲1.2%。 MSCI亞太地區所有國家指數當日上漲2.6%,也創下歷史新高。
Related Articles
Research Alert: Bio-techne: U.s. Academia Grows Modestly, Q3 Fy 26 Eps Meets Consensus
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Bio-Techne delivered Q3 FY 26 (Jun.) adjusted EPS of $0.53, in-line with consensus, while sales declined 2% to $311.4M amid challenging conditions and unfavorable Commercial Supply timing. Double-digit pharma growth for the sixth consecutive quarter helped offset the gradually recovering biotech funding environment. We believe the company's diversified portfolio and strong financial flexibility position Bio-Techne to capitalize on improving market conditions. Management expressed cautious optimism about improving end-market fundamentals, noting early indicators of better alignment between biotech funding and customer purchasing. U.S. academic markets showed stabilization with low-single-digit growth, representing improvement from recent weakness. Protein Sciences revenue declined 1% to $226.2M with 44.2% operating margin, while Diagnostics and Spatial Biology revenue fell 4% to $85.6M but operating margin improved to 12.1% following the Exosome divestiture.
Research Alert: Apo Delivers Strong Q1 2026 Results With Record Fee-related Earnings
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:APO delivered strong Q1 2026 results with record fee-related earnings of $728M (+30% Y/Y) and adjusted net income of $1.94 per share. Total AUM surpassed the $1T milestone at $1.026T (+31% Y/Y) due to record inflows of $115B, while fee-generating AUM was $836B (+40% Y/Y). We think the ALT investment cycle is accelerating with higher private equity monetization activity, positioning APO as a market leader in private credit. Even with negative media on private credit, APO's Credit segment realized $108B in quarterly inflows and outflow of $20B. APO did not provide specific 2026 guidance, but trends are favorable, in our view. Management fees grew 24% Y/Y to $952M, with perpetual capital representing 60% of total AUM. We think APO is well-positioned for accelerated performance fee monetization with $74B in dry powder and superior credit quality at 11 bps losses versus 12 bps industry average. The firm returned $1.5B to shareholders through dividends and repurchases while implementing a new $4.0B buyback program.
Sector Update: Energy Stocks Fall Pre-Bell Wednesday
Energy stocks were lower premarket Wednesday, with the State Street Energy Select Sector SPDR ETF (XLE) retreating by 4%.The United States Oil Fund (USO) was down 7.5%, while The United States Natural Gas Fund (UNG) was 1.4% lower.Front-month US West Texas Intermediate crude oil was down 10% at $91.80 per barrel at the New York Mercantile Exchange. Global benchmark North Sea Brent crude oil fell 9.6% to $99.34 per barrel, and natural gas futures were 2.5% lower at $2.72 per 1 million British Thermal Units.TotalEnergies (TTE) shares were down more than 4% before the opening bell, reversing the 1.4% gain from the prior session. The company said it signed an agreement with Dell Technologies (DELL) and Nvidia (NVDA) to design and install its next high-performance supercomputer, called Pangea 5, in southern France.Equinor (EQNR) shares were down more than 8% premarket after the company reported lower Q1 revenue.Select Water Solutions (WTTR) stock was up over 4% after the company reported better-than-expected Q1 earnings and revenue.